Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
TLRY

Tilray

$165.71

17.56 (11.85%)

, NVS

Novartis

$83.14

0.37 (0.45%)

08:37
10/16/18
10/16
08:37
10/16/18
08:37
Recommendations
Tilray, Novartis analyst commentary  »

Benchmark starts cannabis…

TLRY

Tilray

$165.71

17.56 (11.85%)

NVS

Novartis

$83.14

0.37 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, SNY

Sanofi

$43.45

0.56 (1.31%)

06:10
10/16/18
10/16
06:10
10/16/18
06:10
Periodicals
Pharma pushes back against required listing of drug prices in TV ads, WSJ says »

The pharmaceutical…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

SNY

Sanofi

$43.45

0.56 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

AZN

AstraZeneca

$37.46

0.31 (0.83%)

PFE

Pfizer

$43.11

-0.67 (-1.53%)

LLY

Eli Lilly

$110.69

0.2 (0.18%)

MRK

Merck

$69.46

-0.31 (-0.44%)

GSK

GlaxoSmithKline

$38.87

0.56 (1.46%)

NVS

Novartis

$83.14

0.37 (0.45%)

BMY

Bristol-Myers

$57.59

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

NVS

Novartis

$83.14

0.37 (0.45%)

05:34
10/16/18
10/16
05:34
10/16/18
05:34
Hot Stocks
Novartis: 5-year Cosentyx studies data backs leadership in spondyloarthritis »

Novartis announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

Saturday
AZN

AstraZeneca

$37.15

-0.49 (-1.30%)

, BMY

Bristol-Myers

$57.50

(0.00%)

07:04
10/13/18
10/13
07:04
10/13/18
07:04
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AZN

AstraZeneca

$37.15

-0.49 (-1.30%)

BMY

Bristol-Myers

$57.50

(0.00%)

LLY

Eli Lilly

$110.49

2.54 (2.35%)

GSK

GlaxoSmithKline

$38.31

-0.17 (-0.44%)

JNJ

Johnson & Johnson

$133.78

-0.03 (-0.02%)

MRK

Merck

$69.77

1.41 (2.06%)

NVS

Novartis

$82.77

0.56 (0.68%)

PFE

Pfizer

$43.78

0.97 (2.27%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

NYT

New York Times

$24.98

0.145 (0.58%)

STMP

Stamps.com

$214.32

-0.43 (-0.20%)

AMZN

Amazon.com

$1,788.63

69.51 (4.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

Friday
MYL

Mylan

$32.17

-0.44 (-1.35%)

, TEVA

Teva

$21.42

0.96 (4.69%)

12:36
10/12/18
10/12
12:36
10/12/18
12:36
Hot Stocks
Mylan says it prevails in Copaxone litigation against Teva in appellate court »

Mylan (MYL) announced…

MYL

Mylan

$32.17

-0.44 (-1.35%)

TEVA

Teva

$21.42

0.96 (4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

  • 13

    Nov

TEVA

Teva

$21.01

0.545 (2.66%)

, MYL

Mylan

$32.64

0.03 (0.09%)

10:33
10/12/18
10/12
10:33
10/12/18
10:33
Periodicals
Court upholds ruling that cancels Teva's Copaxone patents, Reuters reports »

A U.S. appeals court has…

TEVA

Teva

$21.01

0.545 (2.66%)

MYL

Mylan

$32.64

0.03 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

  • 13

    Nov

Thursday
NVS

Novartis

$82.21

-2.18 (-2.58%)

, ABBV

AbbVie

$90.77

-2.32 (-2.49%)

16:44
10/11/18
10/11
16:44
10/11/18
16:44
Hot Stocks
Novartis division Sandoz, AbbVie resolve IP related litigation for Hyrimoz »

Sandoz, a Novartis (NVS)…

NVS

Novartis

$82.21

-2.18 (-2.58%)

ABBV

AbbVie

$90.77

-2.32 (-2.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

ABBV

AbbVie

$90.77

-2.32 (-2.49%)

, NVS

Novartis

$82.21

-2.18 (-2.58%)

16:34
10/11/18
10/11
16:34
10/11/18
16:34
Hot Stocks
AbbVie announces Humira patent dispute resolution, terms not stated »

AbbVie (ABBV) announced a…

ABBV

AbbVie

$90.77

-2.32 (-2.49%)

NVS

Novartis

$82.21

-2.18 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

Wednesday
NVS

Novartis

$84.39

-0.69 (-0.81%)

16:36
10/10/18
10/10
16:36
10/10/18
16:36
Hot Stocks
Novartis says Gilenya met primary endpoint in Phase IIIb study »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

TEVA

Teva

$21.12

-0.06 (-0.28%)

12:33
10/10/18
10/10
12:33
10/10/18
12:33
Hot Stocks
Teva, Celltrion announce FDA committee unanimously recommends CT-P10 »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.